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Abstract 
 
Background: Xuefu Zhuyu Tang (XFZYT), first recorded in Correction of Errors in Medical Works by Qing-ren Wang, 
has been proven reliable and effective for curing various diseases such as atherosclerosis, hypertension, hyperlipidemia, and 
angina pectoris. It consists of 11 herbs and two of them, Radix platycodonis and Radix cyathulae, have been traditionally 
considered as guiding herbs and deeply valued by tens of millions of Chinese medicine practitioners. Do Radix 
platycodonis and Radix cyathulae affect the pharmacokinetics of the effective constituent-paeoniflorin of XFZYT? If yes, 
in what way? This study aims to answer these questions.   
Materials and Methods: The medicinal solutions of XFZYT, XFZYT without Radix platycodonis (XFZYT-JG), XFZYT 
without Radix cyathulae (XFZYT-NX), and XFZYT without Radix platycodonis and Radix cyathulae (XFZYT-JG-NX) 
were prepared and administrated to rats in the normal group and the blood-stasis model group by gavage, respectively. The 
blood samples of rats in the normal group were obtained 5, 10, 15, 20, 30, 45, 60, 120, and 240 minutes after gavage; 
whereas the blood samples of rats in the blood-stasis model group were obtained 10, 15, 20, 30, 45, 90, 150, and 240 
minutes after gavage. Biological samples were processed; the assays of specificity, precision, linearity, intra-day and inter-
day precisions, recovery and stability were conducted; high performance liquid chromatography was performed to detect 
paeoniflorin content; and DAS software was adopted to generate pharmacokinetic parameters. Mobile phase was composed 
of acetonitrile and water (16:84), detection wavelength was 230 nm, and riboflavin was set as internal standard substance. 
Results: The pharmacokinetic parameters of the rats in the normal group after oral gavage of XFZYT, XFZYT-JG, 
XFZYT-NX, and XFZYT-JG-NX were Cmax = (0.363±0.248, 0.065±0.020, 0.099±0.033, 0.099±0.020) mg/L, Tmax = 
(0.276±0.084, 0.583±0.342, 0.555±0.228, 0.317±0.033)h, t1/2 = (0.501±0.241, 1.021±0.522, 0.853±0.377, 1.227±0.402) h; 
and AUC0-∞ = (0.381±0.415, 0.13±0.085, 0.166±0.066, 0.185±0.059) mg/L·h.; whereas the pharmacokinetic parameters for 
the rats in the blood-stasis model group after oral gavage of XFZYT, XFZYT-JG, XFZYT-NX, and XFZYT-JG-NX were 
Cmax = (0.315±0.153, 0.215±0.044, 0.228±0.056, 0.248±0.09) mg/L, Tmax = (0.5±0, 0.667±0.129, 0.5±0, 0.542±0.102) h, t1/2 
= (0.408±0.146, 0.813±0.135, 0.708±0.383, 0.741±0.173) h, and AUC 0-∞ = (0.306±0.157, 0.408±0.136, 0.368±0.159, 
0.381±0.246) mg/L·h.  
Conclusion: The guiding herbs, Radix platycodonis and Radix cyathulae, significantly increased the absorption amount and 
rate of paeoniflorin in XFZYT, and accelerated its elimination from the blood.  
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Introduction 
 
Xuefu Zhuyu Tang (XFZYT) was first recorded in Yī Lín Găi Cuò (Correction of Errors in Medical Works) written by 
Qing-ren Wang (1768–1831) (Shoja et al., 2010). Upon an original use of relieving blood stasis in the chest and the 
principle of Traditional Chinese Medicine (TCM) to "treat different diseases in the same way", this formula has centuries of 
clinical use and been proven effective for curing diseases such as atherosclerosis, hypertension, hyperlipidemia, 
thromboembolism, and angina pectoris (Huang et al., 2007; Shi et al., 2013). Pharmacological researches have elucidated 
its mechanisms of protecting the cardiovascular and cerebrovascular system (Yu et al., 1988; Zhang et al., 2010; Jiang and 
Jiang, 2015) and its effects of inducing endothelial progenitor cell angiogenesis, hastening tube formation, regulating blood 
lipid, and protecting neuro (Gao et al., 2010; Lee et al., 2011; Song et al., 2013; Xing et al., 2016).  
The efficacy of herbal medicine has been considered attributable to the synergistic effect of multiple constituents (Ren 
et al., 2008). To support the traditional use of XFZYT and reveal its substance foundation, high-performance liquid 
chromatography-mass spectrometry was performed to identify its antiatherogenic constituents (Liu et al., 2004). A total of 
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103 compounds were unveiled, 35 of which were unambiguously identified (Zhang et al., 2015). However, little attention 
has been paid to the guiding herbs-Radix platycodonis and Radix Cyathulae in XFZYT. These two herbs embody the 
fundamental theory of channel tropism in TCM and are highly valued by tens of millions of TCM practitioners.  
Channel tropism refers to the selective therapeutic effects of Chinese material medica on a certain part of the human 
body; while guiding herb is to direct a formula to certain affected channels/areas of the body and may exert 
obvious/specific therapeutic actions. They are of great significance to the compatibility and clinical utilization of a formula. 
Hereby, to study the mechanism of guiding herb has important significance for TCM. Major investigations involved 
indentifying the similarity in the mechanism of action between guiding herb and active targeting carrier; revealing the 
capacity of guiding herb to regulate qi and blood; interpreting the similarity between channel tropism and systems biology; 
and validating the guiding effect of a single herb or a certain type of herb (Wang and Li, 2002; Zhao and Liu, 2005; Han, 
2008; Liu et al., 2013; Lu, 2004; Chen et al., 2011; Xu et al., 2012). 
All those attempts are beneficial to understand the mechanism; however, the pharmacological mechanism of guiding 
herb in the context of a compound formula has rarely been reported. The effects of Radix platycodonis and Radix cyathulae 
on the effective constituent in XFZYT are still unsealed, and their pharmacokinetic characteristics have yet been identified. 
This study, therefore, aimed at evaluating the in vivo effects of Radix platycodonis and Radix cyathulae on paeoniflorin 
pharmacokinetics of XFZYT. The pharmacokinetic parameters of XFZYT-JG (XFZYT without Radix Platycodonis), 
XFZYT-NX (XFZYT without Radix Cyathulae), and XFZYT-JG-NX (XFZYT without both Radix Platycodonis and Radix 
Cyathulae) were measured and compared with that of XFZYT. The results indicated that Radix platycodonis and Radix 
cyathulae could increase the absorption amount and rate of paeoniflorin of XFZYT in rats, and accelerate its elimination 
from the blood. To our knowledge, this is the first investigation that provides evidence to reveal the effects of guiding herbs 
on the pharmacokinetics in the context of a compound formula. 
 
Materials and Methods 
Equipment  
 
The following pieces of equipment were used: ultraviolet-visible (UV-Vis) detector (SPD-10Avp) and high 
performance liquid chromatograph (HPLC, LC-10ATvp) (Shimadzu Corporation, Japan); FA1004 electronic scales 
(Shanghai liangping Instrument Co., Ltd. Shanghai, China); LG15-W high speed micro centrifuge (Beijing medical 
centrifuge factory, Beijing, China). Water used in the experiment was purified by a Milli-Q water purification system 
(Millipore, Billerica, MI, USA). 
 
Chemicals 
 
XFZYT consists of 11 Chinese materia medica, namely 12g Semen Persicae (Tao-Ren), 9g Radix Angelicae Sinensis 
(Dang-Gui), 4.5g Rhizoma Chuanxiong (Chuan-Xiong), 9g Flos Carthami (Hong-Hua), 6g Radix Paeoniae Rubra (Chi-
Shao), 9g Radix Rehmanniae (Di-Huang), 6g Fructus Aurantii (Zhi-Qiao), 3g Radix Bupleuri (Chai-Hu), 4.5g Radix 
Platycodonis (Jie-Geng), 9g Radix cyathulae (Niu-Xi), and 6g Radix et Rhizoma Glycyrrhizae (Gan-Cao). All herbs, 
commercially available as dried matter, were purchased from Sichuan BenCaoTang Pharmaceutical Co., Ltd. (Chengdu, 
China). The voucher specimens were deposited at the herbarium of the Chengdu Qihuang Bio-Tech Institute (Chengdu, 
China). 
Paeoniflorin reference substances (98% purity, batch No.: 121207) were obtained from Chengdu Pufei De Biotech 
Co., Ltd. (Chengdu, China). Riboflavin reference substances (98% purity, batch No.: 130114) were obtained from Chengdu 
PureChem-Standard Co., Ltd. (Chengdu, China). Glucan T500 was obtained from Beijing YaAnDa Biotechnology Co., 
Ltd. (Beijing, China). Chromatographically pure carbinol and acetonitrile were required. 
 
Animals 
 
Forty-eight SPF Sprague-Dawley rats of either sex weighing 180–220g (6 weeks of age) were obtained from Sichuan 
Academy of Chinese Medicine Sciences (Chengdu, China). Animals were housed in standard plastic cages under automatic 
12 h light/dark cycles at 20–24 °C and relative humidity of 40–70%, with free access to purified water. All animals were 
fed with pellet diet (15–25g/rat/day) provided by Chengdu Dashuo Laboratory Animal Co., Ltd. (Chengdu, China). The 
experimental procedures were carried out in accordance with the Guidelines for Animal Experimentation and approved by 
the Institutional Review Committee on Animal Care and Use at Chengdu Qihuang Bio-Tech Institute (Chengdu, China). 
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Chromatographic Conditions 
 
The experiment was performed on a Diamonsil C18 chromatographic column (250 mm × 4.6 mm, 5 µm) at 30 ℃; the 
mobile phase was composed of acetonitrile and water (16:84); the flow velocity was 1.0 mL·min-1, the detection 
wavelength was 230 nm, the riboflavin was set as internal standard substance, and the injection volume was 20 µL. 
 
Medicinal Solution Preparation 
 
According to the traditional formulae, the medicinal materials of XFZYT (totally weight of 78 g), XFZYT-JG (73.5 
g), XFZYT-NX (69 g), and XFZYT-JG-NX (64.5 g) were accurately weighed, multiplied by 45 to 3 510 g, 3 307.5 g, 3 105 
g, and 2 902.5 g, respectively, and immersed in 35 100 mL, 33 075 mL, 31 050 mL, and 29 025 mL of water (v/v, 1:10), 
respectively, for 30 min at room temperature. XFZYT, XFZYT-JG, XFZYT-NX, and XFZYT-JG-NX were decocted 30 
min for 3 times, respectively. After filtration and concentration in a rotatory evaporator for 8 hrs, the aqueous extract of 
each sample was dried at 45℃ in a vacuum drying oven to obtain 426g original extract powder of XFZYT, 1 054g of 
XFZYT-JG, 948g of XFZYT-NX, and 650 g of XFZYT-JG-NX. The mass fraction of paeoniflorin in original extract 
power was 2.290 mg·g-1 for XFZYT, 2.620 mg·g-1 for XFZYT-JG, 3.366 mg·g-1 for XFZYT-NX, and 3.120 mg·g-1 for 
XFZYT-JG-NX. An amount of 4 g extractive powder of each sample was accurately weighed, dissolved in 4.0 mL, 4.6mL, 
5.9mL, and 5.4 mL of water, respectively, and swirled to mix thoroughly and obtain the medicinal solutions for oral 
gavage. 
An amount of 1.0 g of Glucan T500 was accurately weighed and dissolved with 20 mL of 0.9% sodium chloride 
injection to get 5% glucan T500 solution. All solutions were stored at 0°C until analysis. 
 
Stock solution 
 
An amount of 6.63 mg of paeoniflorin reference substance was accurately weighed, set into a brown and dry 50 mL 
volumetric flask, diluted with methyl alcohol to volume, and then shaken well. A paeoniflorin stock solution with a 
concentration of 130.0 µg·mL-1 was prepared and stored at 0°C.  
An amount of 4.8 mg of riboflavin reference substance was accurately weighed, set into a brown and dry 50 mL 
volumetric flask, diluted with a 70% methanol aqueous solution to volume, and then shaken well. An internal standard 
stock solution with a concentration of 94.1 µg·mL-1 was prepared and stored at 0°C. A volume of 1 666.7 µL of internal 
standard stock solution was diluted with water to 100 mL to obtain internal working standard solution with a concentration 
of 1.57 µg/mL. 
 
Administration of chemicals 
 
The rats were randomized into two groups, namely the normal group and the blood-stasis model group. Then, 24 
animals in each group of either sex were randomly assigned to 4 groups (6 in each group of either sex). The animals were 
fasting for 12 hrs and allowed free access to water.  
Each rat in the blood-stasis model group was injected intravenously (caudal vein) with 5% glucan T500 solution (2 
mL·kg-1) (Li Yikui, 1991). Thirty min later, the medical solutions of XFZYT, XFZYT-JG, XFZYT-NX, and XFZYT-JG-NX 
(5 mL·kg-1) were administrated by oral gavage to the rats in the normal group and the blood stasis group, respectively. Each 
group was given equal volume of paeoniflorin (11.452 mg·kg-1). Administration was performed once a day. 
 
Blood sample collection 
 
Blood samples were collected from the orbital venous plexus of rats in the normal group 5, 10, 15, 20, 30, 45, 60, 120, 
and 240 min after administration of gavage; whereas blood samples were collected from the orbital venous plexus of rats in 
the blood-stasis model group 10, 15, 20, 30, 45, 90, 150, and 240 min after administration of gavage. After allowing the 
tube to clot for 20 min in a vertical position, the blood samples were centrifuged at 5 000 r·min-1 for 10 min, the serum was 
then separated and stored in a centrifuge tube at -20℃ for assay.  
 
Blood sample processing 
 
To 100 µL of serum, 250 µL of acetonitrile and 20 µL of working internal standard solution were added. The mixture 
was lightly shaken in vortex and then centrifuged at 5 000 r·min-1 for 10 min. Once centrifuged, the supernatant was 
transferred and evaporated under nitrogen in a water bath at 40 ℃, and 100 µL of water were added to redissolve it. 
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Statistical analysis 
 
Serum-concentration - time data were analyzed with DAS2.0 software to generate pharmacokinetic parameters. 
Experimental data were expressed as x s and statistically analyzed by SPSS13.0 software. One-way ANOVA was 
applied for the pharmacokinetic parameters of AUC(0-t) and Cmax , and non-parametric test for Ka, Ke, Tmax, and t1/2. 
Differences were deemed statistically significant at p < 0.05.  
 
Results 
Specificity 
 
To paeoniflorin reference substance, internal standard substance solution, blank serum solution and serum solution 
after treatment were added. An aliquot of the resulting solution was injected into HPLC system, and chromatograms were 
recorded (Figure 1). The paeoniflorin and endogenous impurities were confirmed separate well; the degree of separation 
was found to be 1.8; and the retention time was 15.9 min for the paeoniflori, and 9.5 min for the internal standard 
substance. 
 
              Reference substance        Blank serum         Serum after treatment 
Figure 1: HPLC chromatograms of paeoniflorin and internal standard substance(t/min) 
 
Precision  
     
    Paeoniflorin reference substance solution (0.65 mg·L-1) was accurately measured out, an aliquot of the resulting solution 
was injected for 6 successive times. Results showed that the RSD of paeoniflorin peak area was 0.4%, indicating that the 
present methods were reliable and reproducible for quantitative determination of analytes.  
 
Linearity and range  
 
To 100 µL of blank serum, paeoniflorin working solution, 20 µL internal standard working solution and 250 µL 
acetonitrile protein-precipitation were accurately added. The procedure was conducted to obtain a series of blank serum 
sample solutions with a paeoniflorin concentration of 0.01, 0.02, 0.06, 0.1, 0.2, 0.4, 0.6, and 1.0 µg·mL-1, respectively. The 
regression equations of serum sample were expressed as Y=1.8925X﹢0.0029 (weight 1/x2, r =0.9996), where the Y 
represented peak area ratio between paeoniflorin and riboflavin, and the X represented mass concentration. 
 
Intra-day and inter-day precisions 
 
The serum samples containing paeoniflorin with a mass concentration of 0.01, 0.1, and 1.0 µg·mL-1, respectively, were 
prepared in quintuplicate and analyzed for six repetitive injections per day for three consecutive days. Results revealed for 
the blank serum samples containing paeoniflorin at 0.01, 0.1, and 1.0 µg·mL-1, the RSDs of intra-day precision were 3.4%, 
3.2%, and 3.2%, respectively; and the RSDs of inter-day precision were 4.2%, 3.1%, and 4.4%, respectively. 
 
Recovery rate 
 
The serum samples containing paeoniflorin with a mass concentration of 0.01, 0.1, and 1.0 µg·mL-1, respectively, were 
prepared in quintuplicate and measured. The recovery rate was calculated by plotting the ratio of peak area between 
paeoniflorin and internal standard substance to standard curve. Results revealed that for the serum samples containing 
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paeoniflorin at 0.01, 0.1, and 1.0 µg·mL-1, the recovery rates were 102.5%, 101.3%, and 100.0%, respectively; and the 
RSDs were 0.8%, 0.9%, and 0.4%, respectively. 
 
Stability 
 
The serum sample solutions were prepared in quadruplicate and stored at -20 ℃. The stability of sample solutions was 
evaluated at room temperature by replicating the injection at 0, 1, 3, and 7 d. All serum samples were shown to be stable 
within 7 days. 
 
Pharmacokinetics  
 
Chromatograms were recorded and the peak area ratios between paeoniflorin and internal standard substance were 
plotted to the standard curve equation to calculate paeoniflorin concentration in serum (Figures 2 and 3). Data of 
concentration-time curve were analyzed. The Cmax and Tmax were obtained directly from the concentration-time curve, 
while the rest parameters were calculated with DAS 2.0 software (Tables 1 and 2). The results indicated that for the normal 
rats, the usage of Radix platycodonis and/or Radix cyathulae could increase the absorption of paeoniflorin and accelerate its 
elimination from the blood; whereas for the blood-stasis rats, the usage of Radix platycodonis or/and Radix cyathulae could 
increase the absorption of paeoniflorin, sole usage of Radix platycodonis and combining use of Radix platycodonis and 
Radix cyathulae could accelerate the elimination of paeoniflorin from the blood. 
  
Figure 2: Mean c-t curve of rats in the normal 
group 
  Figure 3: Mean c-t curve of rats in the 
blood-stasis group 
  
Table 1: Paeoniflorin pharmacokinetic parameters of rats in normal group after administration of oral gavage（n=6） 
Parameter Unit 
Parameter values ( x s ) 
XFZYT XFZYT-JG XFZYT-NX XFZYT-JG-NX 
C
o
m
p
artm
en
t 
M
o
d
el 
t1/2 h 0.501±0.241② ③ ④ 1.021±0.522① 0.853±0.377① 1.227±0.402① 
Ke h-1 1.638±0.682② ③ ④ 0.84±0.418① 0.972±0.445① 0.615±0.187① 
V1/F L·kg-1 36.521±26.499② ③ ④ 150.383±73.977① 93.155±40.472① 111.528±27.267① 
CL/F L·h-1·kg-1 69.846±79.426 110.388±43.702 79.524±33.226 66.105±16.271 
AUC(0-t) mg·L-1·h 0.356±0.392 0.112±0.06 0.149±0.069 0.146±0.049 
AUC(0-∞) mg·L-1·h 0.381±0.415 0.13±0.085 0.166±0.066 0.185±0.059 
Ka h-1 30.905±31.196③ 7.549±8.004 8.006±8.197①④ 14.114±10.323③ 
S
tatistical  
M
o
m
en
t 
AUC(0-t)z mg·L-1·h 0.408±0.418 0.113±0.063 0.148±0.069 0.146±0.048 
AUC(0-∞)z mg·L-1·h 0.451±0.447 0.129±0.086 0.168±0.068 0.182±0.052 
MRT(0-t) h 0.911±0.435 1.397±0.165 1.175±0.293 1.188±0.419 
MRT(0-∞) h 1.214±0.716 1.836±0.479 1.677±0.407 1.955±0.703 
t1/2z h 0.724±0.516 1.168±0.368 1.098±0.373 1.304±0.507 
Tmax h 0.276±0.084③ 0.583±0.342 0.555±0.228① 0.317±0.033 
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CLz/F L·h-1·kg-1 67.017±86.091 111.117±43.201 78.495±32.506 66.657±16.165 
Vz/F L·kg-1 41.972±30.599② ③ ④ 177.692±76.789① 119.686±46.165① 120.396±43.81① 
Zeta  1.397±0.839 0.635±0.163 0.688±0.201 0.609±0.247 
Cmax mg·L-1 0.363±0.248② ③ ④ 0.065±0.02① ④ 0.099±0.033① 0.099±0.02① ② 
z: for the parameter of statistical moment; ①compared with XFZYT, P＜0.05; ② compared with XFZYT-JG, P＜0.05; 
③compared with XFZYT-NX, P＜0.05; ④compared with XFZYT-JG-NX, P＜0.05.  
 
Table 2: Paeoniflorin pharmacokinetic parameters of rats in blood-stasis group after administration of oral gavage（n=6） 
Parameter Unit 
Parameter values ( x s ) 
XFZYT XFZYT-JG XFZYT-NX XFZYT-JG-NX 
C
o
m
p
artm
en
t 
M
o
d
el 
t1/2 h 0.408±0.146② ④ 0.813±0.135① 0.708±0.383 0.741±0.173① 
Ke h-1 1.876±0.605② ④ 0.871±0.136① 1.289±0.744 0.977±0.218① 
V1/F L·kg-1 26.538±11.444 34.81±8.663 31.865±7.669 39.643±16.814 
CL/F L·h-1·kg-1 49.408±31.718 30.172±7.744 40.062±26.515 41.177±25.269 
AUC(0-t) mg·L-1·h 0.288±0.154 0.362±0.125 0.338±0.139 0.349±0.227 
AUC(0-∞) mg·L-1·h 0.306±0.157 0.408±0.136 0.368±0.159 0.381±0.246 
Ka h-1 6.475±3.758 3.753±2.423 4.543±2.279 6.131±2.462 
S
tatistical  
M
o
m
en
t 
AUC(0-t)z mg·L-1·h 0.289±0.157 0.364±0.123 0.338±0.141 0.352±0.226 
AUC(0-∞)z mg·L-1·h 0.307±0.161 0.421±0.128 0.369±0.16 0.386±0.239 
MRT(0-t) h 0.81±0.1 1.389±0.157 1.229±0.288 1.152±0.295 
MRT(0-∞) h 0.964±0.13 1.971±0.178 1.514±0.456 1.47±0.415 
t1/2z h 0.545±0.112 1.271±0.169 0.886±0.325 0.894±0.299 
Tmax h 0.5±0② 0.667±0.129① ③ 0.5±0② 0.542±0.102 
CLz/F L·h-1·kg-1 49.974±33.493 28.971±6.932 40.271±27.6 40.008±23.675 
Vz/F L·kg-1 37.508±20.468 53.815±16.379 42.789±11.053 46.495±19.393 
Zeta  1.316±0.263 0.554±0.074 0.895±0.402 0.842±0.25 
Cmax mg·L-1 0.315±0.153 0.215±0.044 0.228±0.056 0.248±0.09 
z: for the parameter of statistical moment; ①compared with XFZYT, P＜0.05; ②compared with XFZYT-JG, P＜0.05; 
③compared with XFZYT-NX, P＜0.05; ④compared with XFZYT-JG-NX, P＜0.05.  
 
Discussion 
 
XFZYT has been widely used to cure various diseases caused by blood-stasis with reliable and satisfactory efficacy. It 
has long been considered an embodiment of the channel tropism theory with emphasis on Radix platycodonis and Radix 
cyathulae as guiding herbs. In the present study, we investigated the in vivo effects of those two herbs on the paeoniflorin 
pharmacokinetics of XFZYT. Our findings suggest Radix platycodonis and Radix cyathulae can increase the absorption 
amount and rate of paeoniflorin in XFZYT, and accelerate its elimination from the blood. Herein, we infer that the 
accelerated elimination may imply an increased distribution of the active constituents from the blood to the tissues; and the 
channel tropism effect of the guiding herbs may be attributed to their influences on the pharmacokinetic process of the 
effective constituent.  
Selecting the appropriate index component for detection is essential for conducting the pharmacokinetic research in 
vivo. In this study, paeoniflorin was used as an index component for detection for two reasons: 1) it has been proven 
effective in inhibiting platelet aggregation, dilating blood vessel, and increasing coronary flow (Yuan and Jing, 2011), 
which are completely in line with the blood-invigorating and stasis-dissolving function of XFZYT; 2) our preliminary 
experiments revealed that the content of paeoniflorin of Radix Paeoniae Rubra was comparatively high and detectable; 
whereas the content of hydroxysafflor yellow A of Flos Carthami was extremely low or even undetectable, and sodium 
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ferulate (the main component of blood-invigorating and stasis-dissolving Radix Angelicae Sinensis and Rhizoma 
Chuanxiong) was metabolized very fast in vivo and at the minimum limit of detection. 
Channel tropism is the core principle of TCM theory and the bridge between TCM theory and clinical practices 
(Huang and Tang, 2009). The studies of channel tropism and guiding herbs are beneficial for the efficient utilization and 
modernization of TCM. However, researches on the pharmacokinetic characteristics of guiding herb in the context of a 
formula were rarely reported. In this study, we applied the method of "decomposing formula" by removing Radix 
platycodonis from XFZYT (XFZYT-JG), Radix cyathulae from XFZYT (XFZYT-NX), and both Radix platycodonis and 
Radix cyathulae from XFZYT (XFZYT-JG-NX), respectively. And then by comparing their pharmacokinetic parameters 
with that of XFZYT, we validated Radix platycodonis and Radix cyathulae's effects on the pharmacokinetics of 
paeoniflorin. This approach might provide a valuable reference for further research of such kind. 
 
Conclusions 
 
This study, to the best of our knowledge, reveals for the first time that Radix platycodonis and Radix cyathulae 
increase the absorption amount and rate of paeoniflorin of XFZYT in rats, and accelerate its elimination from the blood. 
The study also provides evidence that reveals the effects of the guiding herbs on the pharmacokinetics of the compound in 
rat.  
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